deSavigny, Don

The challenge to avoid anti-malarial medicine stock-outs in an era of funding partners: the case of Tanzania.

Journal Title: 
Publication Date: 
Jun 04, 2014

BACKGROUND: Between 2007 and 2013, the Tanzanian public sector received 93.1 million doses of first-line anti-malarial artemisinin-based combination therapy (ACT) in the form of artemether-lumefantrine entirely supplied by funding partners.